Skip to main content
. 2023 Mar 19;12(3):748. doi: 10.3390/antiox12030748
AGEs Advanced glycation end-products
CLD Chronic liver disease
CML Nε-(Carboxymethyl)lysine
COL-I Collagen type I
CRP C-Reactive protein
CVD Cardiovascular disease
3-DG-AGEs 3-Deoxyglucosone-derived AGEs
DHAP Dihydroxyacetone phosphate
DN-HD Diabetic nephropathy with hemodialysis
EC Endothelial cells
ECM Extracellular matrix
Fru Fructose
Fru-AGEs Fructose-derived AGEs
GA Glyceraldehyde
GA-AGEs Glyceraldehyde-derived AGEs
GA-3-P Glyceraldehyde-3-phosphate
GAPDH Glyceraldehyde-3-phosphate dehydrogenase
GLAP 3-Hydroxy-5-hydroxymethyl-pyridinium compound
Glu Glucose
Glu-AGEs Glucose-derived AGEs
Glycol-AGEs Glycolaldehyde-derived AGEs
GO Glyoxal
GO-AGEs Glyoxal-derived AGEs
γ-GTP γ-Glutamyl transpeptidase
HCC Hepatocellular carcinoma
HFCS High-fructose corn syrup
hiPSC Human induced pluripotent stem cells
hiPSC-HLC HLC differentiated from hiPSC
HLC Hepatocyte-like cells
hnRNPM Heterogeneous nuclear ribonucleoprotein M
HO-1 Hemeoxygenase-1
HOMA-IR Homeostasis model assessment of IR
Hsc70 Heat shock cognate 70
HSC Hepatic stellate cells
ICAM-1 Intercellular adhesion molecule-1
IL Interleukin
IR Insulin resistance
MCP-1 Monocyte chemoattractant protein-1
MG-H1 Methylglyoxal-derived hydroimidazolone compound
MGO Methylglyoxal
MGO-AGEs Methylglyoxal-derived AGEs
MS Metabolic syndrome
NAFL Nonalcoholic fatty liver
NAFLD Nonalcoholic fatty liver disease
NASH Nonalcoholic steatohepatitis
NBNC-HCC Non-B, non-C HCC
NF-κB Nuclear factor kappa B
NOX Nicotinamide adenine dinucleotide phosphate-reduced oxidase
Nrf2 Nuclear factor erythroid 2-related factor 2
RAGE Receptor for AGEs
sRAGE Soluble form of RAGE
RasGRP2 Ras guanyl nucleotide releasing protein 2
ROS Reactive oxygen species
α-SMA α-smooth muscle actin
SSB Sugar-sweetened beverages
TAGE Toxic AGEs
T2DM Type 2 diabetes mellitus
TGF-β1 Transforming growth factor-β1
TNF-α Tumor necrosis factor-α
VE Vascular endothelial
VEGF Vascular endothelial growth factor